Showing results (11-20 of 162) with videos related to
Sort By:
Pageof 17
Presse Medicale (Paris, France : 1983)|May 8, 2003
[From hepatic steatosis due to obesity to cirrhosis, in the absence of alcoholic intoxication]Dominique LarreySeminars in Liver Disease|May 23, 2002
Epidemiology and individual susceptibility to adverse drug reactions affecting the liverDominique LarreyEuropean Journal of Gastroenterology & Hepatology|January 28, 2005
Drug-induced acute liver failureDominique Larrey, Georges-Philippe PageauxGastroenterologie Clinique Et Biologique|October 30, 2007
[Chronic hepatitis C: management of side effects of treatment]Dominique Larrey, Patrice Couzigou, Jacques DenisWorld Journal of Gastroenterology|November 18, 2015
Hepatitis C virus infection: Are there still specific problems with genotype 3?Claire Gondeau, Georges Philippe Pageaux, Dominique LarreyAddiction Biology|March 20, 2002
Liver transplantation for alcoholic liver diseaseGeorges-Philippe Pageaux, Pascal Perney, Dominique LarreyExpert Opinion on Drug Safety|November 22, 2018
Liver safety parameters of ulipristal acetate for the treatment of uterine fibroids: a comprehensive review of the clinical development programJacques Donnez, Pablo Arriagada, Marcin Marciniak, et al.Liver International : Official Journal of the International Association for the Study of the Liver|December 15, 2022
Long-term hepatic safety of lomitapide in homozygous familial hypercholesterolaemiaDominique Larrey, Laura D'Erasmo, Sallyann O'Brien, et al.Medicines (Basel, Switzerland)|September 21, 2017
Traditional Chinese Medicine (TCM) and Herbal Hepatotoxicity: RUCAM and the Role of Novel Diagnostic Biomarkers Such as MicroRNAsRolf Teschke, Dominique Larrey, Dieter Melchart, et al.Patient Preference and Adherence|June 13, 2014
Patient adherence issues in the treatment of hepatitis CDominique Larrey, Marie-Pierre Ripault, Georges-Philippe PageauxPageof 17